Dimed S.A. Distribuidora de Medicamentos (PNVL3) - Net Assets
Based on the latest financial reports, Dimed S.A. Distribuidora de Medicamentos (PNVL3) has net assets worth R$1.32 Billion BRL (≈ $258.42 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (R$3.71 Billion ≈ $727.95 Million USD) and total liabilities (R$2.39 Billion ≈ $469.52 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Dimed S.A. Distribuidora de Medicamentos (PNVL3) strategic investment index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | R$1.32 Billion |
| % of Total Assets | 35.5% |
| Annual Growth Rate | 11.63% |
| 5-Year Change | 22.53% |
| 10-Year Change | 235.87% |
| Growth Volatility | 16.98 |
Dimed S.A. Distribuidora de Medicamentos - Net Assets Trend (2000–2025)
This chart illustrates how Dimed S.A. Distribuidora de Medicamentos's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see PNVL3 stock market capitalisation.
Annual Net Assets for Dimed S.A. Distribuidora de Medicamentos (2000–2025)
The table below shows the annual net assets of Dimed S.A. Distribuidora de Medicamentos from 2000 to 2025. Also explore PNVL3 shareholders equity momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | R$1.28 Billion ≈ $251.52 Million |
+3.82% |
| 2024-12-31 | R$1.23 Billion ≈ $242.27 Million |
+5.22% |
| 2023-12-31 | R$1.17 Billion ≈ $230.25 Million |
+5.89% |
| 2022-12-31 | R$1.11 Billion ≈ $217.44 Million |
+5.92% |
| 2021-12-31 | R$1.05 Billion ≈ $205.28 Million |
+3.52% |
| 2020-12-31 | R$1.01 Billion ≈ $198.31 Million |
+92.81% |
| 2019-12-31 | R$524.18 Million ≈ $102.85 Million |
+12.99% |
| 2018-12-31 | R$463.91 Million ≈ $91.03 Million |
+8.71% |
| 2017-12-31 | R$426.75 Million ≈ $83.74 Million |
+11.82% |
| 2016-12-31 | R$381.65 Million ≈ $74.89 Million |
+10.90% |
| 2015-12-31 | R$344.14 Million ≈ $67.53 Million |
+10.55% |
| 2014-12-31 | R$311.30 Million ≈ $61.08 Million |
+12.43% |
| 2013-12-31 | R$276.90 Million ≈ $54.33 Million |
+18.51% |
| 2012-12-31 | R$233.64 Million ≈ $45.84 Million |
+17.26% |
| 2011-12-31 | R$199.24 Million ≈ $39.10 Million |
+15.15% |
| 2010-12-31 | R$173.03 Million ≈ $33.95 Million |
+13.94% |
| 2009-12-31 | R$151.86 Million ≈ $29.80 Million |
+16.10% |
| 2008-12-31 | R$130.81 Million ≈ $25.67 Million |
+4.32% |
| 2007-12-31 | R$125.39 Million ≈ $24.60 Million |
+6.49% |
| 2006-12-31 | R$117.74 Million ≈ $23.10 Million |
+8.83% |
| 2005-12-31 | R$108.19 Million ≈ $21.23 Million |
+7.98% |
| 2004-12-31 | R$100.20 Million ≈ $19.66 Million |
+7.02% |
| 2003-12-31 | R$93.62 Million ≈ $18.37 Million |
+5.87% |
| 2002-12-31 | R$88.44 Million ≈ $17.35 Million |
+3.30% |
| 2001-12-31 | R$85.61 Million ≈ $16.80 Million |
+4.47% |
| 2000-12-31 | R$81.94 Million ≈ $16.08 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Dimed S.A. Distribuidora de Medicamentos's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 15696.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | R$90.52 Million | 7.06% |
| Common Stock | R$1.21 Billion | 94.60% |
| Other Comprehensive Income | R$90.52 Million | 7.06% |
| Total Equity | R$1.28 Billion | 100.00% |
Dimed S.A. Distribuidora de Medicamentos Competitors by Market Cap
The table below lists competitors of Dimed S.A. Distribuidora de Medicamentos ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Oatly Group AB ADR
NASDAQ:OTLY
|
$383.13 Million |
|
Korea Electric Terminal
KO:025540
|
$383.18 Million |
|
Wuxi Smart Auto-control Engineering Co Ltd
SHE:002877
|
$383.24 Million |
|
Companhia Brasileira de Distribuição
MX:CBDN
|
$383.53 Million |
|
VST Industries Limited
NSE:VSTIND
|
$383.07 Million |
|
Suzhou Industrial Park Heshun Electric Co Ltd
SHE:300141
|
$382.97 Million |
|
Libra Insurance Company Ltd
TA:LBRA
|
$382.93 Million |
|
Ranger Energy Services Inc
NYSE:RNGR
|
$382.93 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dimed S.A. Distribuidora de Medicamentos's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,234,714,000 to 1,281,851,000, a change of 47,137,000 (3.8%).
- Net income of 124,605,000 contributed positively to equity growth.
- Dividend payments of 26,455,000 reduced retained earnings.
- Share repurchases of 7,775,000 reduced equity.
- New share issuances of 1,914,000 increased equity.
- Other comprehensive income increased equity by 87,264,000.
- Other factors decreased equity by 132,416,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | R$124.61 Million | +9.72% |
| Dividends Paid | R$26.45 Million | -2.06% |
| Share Repurchases | R$7.78 Million | -0.61% |
| Share Issuances | R$1.91 Million | +0.15% |
| Other Comprehensive Income | R$87.26 Million | +6.81% |
| Other Changes | R$-132.42 Million | -10.33% |
| Total Change | R$- | 3.82% |
Book Value vs Market Value Analysis
This analysis compares Dimed S.A. Distribuidora de Medicamentos's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.53x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 18.26x to 1.53x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | R$0.72 | R$13.07 | x |
| 2005-12-31 | R$0.77 | R$13.07 | x |
| 2006-12-31 | R$0.84 | R$13.07 | x |
| 2007-12-31 | R$0.90 | R$13.07 | x |
| 2008-12-31 | R$0.94 | R$13.07 | x |
| 2009-12-31 | R$1.10 | R$13.07 | x |
| 2010-12-31 | R$1.25 | R$13.07 | x |
| 2011-12-31 | R$1.45 | R$13.07 | x |
| 2012-12-31 | R$1.71 | R$13.07 | x |
| 2013-12-31 | R$2.02 | R$13.07 | x |
| 2014-12-31 | R$2.28 | R$13.07 | x |
| 2015-12-31 | R$2.52 | R$13.07 | x |
| 2016-12-31 | R$2.79 | R$13.07 | x |
| 2017-12-31 | R$3.12 | R$13.07 | x |
| 2018-12-31 | R$3.40 | R$13.07 | x |
| 2019-12-31 | R$3.86 | R$13.07 | x |
| 2020-12-31 | R$6.67 | R$13.07 | x |
| 2021-12-31 | R$6.98 | R$13.07 | x |
| 2022-12-31 | R$7.43 | R$13.07 | x |
| 2023-12-31 | R$7.84 | R$13.07 | x |
| 2024-12-31 | R$8.21 | R$13.07 | x |
| 2025-12-31 | R$8.53 | R$13.07 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dimed S.A. Distribuidora de Medicamentos utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.72%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.26%
- • Asset Turnover: 1.44x
- • Equity Multiplier: 2.99x
- Recent ROE (9.72%) is below the historical average (12.12%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 3.61% | 0.67% | 2.99x | 1.80x | R$-5.24 Million |
| 2001 | 8.13% | 1.56% | 2.85x | 1.83x | R$-1.60 Million |
| 2002 | 6.98% | 1.29% | 3.30x | 1.64x | R$-2.67 Million |
| 2003 | 10.71% | 1.88% | 3.10x | 1.84x | R$663.80K |
| 2004 | 11.47% | 1.98% | 3.22x | 1.80x | R$1.48 Million |
| 2005 | 11.80% | 1.97% | 2.98x | 2.01x | R$1.95 Million |
| 2006 | 12.23% | 1.96% | 3.13x | 1.99x | R$2.63 Million |
| 2007 | 11.30% | 1.70% | 3.29x | 2.02x | R$1.63 Million |
| 2008 | 7.41% | 1.04% | 3.38x | 2.11x | R$-3.39 Million |
| 2009 | 19.56% | 2.76% | 3.23x | 2.19x | R$14.51 Million |
| 2010 | 17.78% | 2.59% | 3.15x | 2.18x | R$13.47 Million |
| 2011 | 18.78% | 2.78% | 3.04x | 2.22x | R$17.50 Million |
| 2012 | 20.16% | 3.09% | 3.04x | 2.14x | R$23.74 Million |
| 2013 | 20.28% | 3.23% | 2.90x | 2.17x | R$28.46 Million |
| 2014 | 15.86% | 2.62% | 2.62x | 2.31x | R$18.23 Million |
| 2015 | 13.15% | 2.28% | 2.61x | 2.21x | R$10.85 Million |
| 2016 | 13.90% | 2.49% | 2.59x | 2.15x | R$14.89 Million |
| 2017 | 14.01% | 2.65% | 2.38x | 2.23x | R$17.12 Million |
| 2018 | 16.16% | 3.08% | 2.43x | 2.16x | R$28.59 Million |
| 2019 | 14.64% | 2.82% | 1.87x | 2.79x | R$24.34 Million |
| 2020 | 5.56% | 1.99% | 1.28x | 2.17x | R$-44.91 Million |
| 2021 | 7.59% | 2.46% | 1.35x | 2.28x | R$-25.19 Million |
| 2022 | 7.79% | 2.16% | 1.46x | 2.47x | R$-24.47 Million |
| 2023 | 7.92% | 2.08% | 1.45x | 2.62x | R$-24.44 Million |
| 2024 | 8.55% | 2.13% | 1.46x | 2.74x | R$-17.96 Million |
| 2025 | 9.72% | 2.26% | 1.44x | 2.99x | R$-3.58 Million |
Industry Comparison
This section compares Dimed S.A. Distribuidora de Medicamentos's net assets metrics with peer companies in the Drug Manufacturers - General industry.
Industry Context
- Industry: Drug Manufacturers - General
- Average net assets among peers: $45,603,850,000
- Average return on equity (ROE) among peers: 24.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dimed S.A. Distribuidora de Medicamentos (PNVL3) | R$1.32 Billion | 3.61% | 1.82x | $383.08 Million |
| Eli Lilly and Company (LILY34) | $14.01 Billion | 19.54% | 1.77x | $853.51 Billion |
| Pfizer Inc (PFIZ34) | $77.20 Billion | 28.47% | 1.35x | $147.67 Billion |
About Dimed S.A. Distribuidora de Medicamentos
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil.